Final week, at the very least one scientific journal acquired a letter from a prime U.S. lawyer asking it to reply to alleged bias. Now, one of many world’s main medical journals, has acquired an identical inquiry as properly.
The New England Journal of Drugs’s editor in chief, Eric Rubin, acquired a letter from the interim U.S. lawyer for the District of Columbia, Edward R. Martin Jr. in current days wherein the prosecutor requested six questions, largely about alleged bias within the choice to publish unspecified content material. The journal instructed STAT it responded by affirming its dedication to evidence-based suggestions and editorial independence.
“As training physicians, our editors acknowledge our accountability to docs and sufferers. We use rigorous peer assessment and editorial processes to make sure the objectivity and reliability of the analysis we publish,” Rubin wrote in his response. “We help the editorial independence of medical journals and their First Modification rights to free expression. The Journal actively fosters scholarly scientific dialogue and stays steadfast in its dedication to supporting authors, readers, and sufferers.”
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
View All Plans
